North Ryde, Australia Clinical Trials

A listing of North Ryde, Australia clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 111 clinical trials
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

The objectives of this study are to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06651600 (200 mg for 8 weeks followed by 50 mg for 4 weeks) dosed once daily and PF-06700841 (60 mg for 12 weeks) dosed once daily during an induction period of 12 weeks, followed …

mercaptopurine
azathioprine
antibiotics
infliximab
crohn's disease
Concord Repatriation General Hospital
 (4.8 away) Contact site
  • 1357 views
  • 23 Nov, 2020
  • +278 other locations
A Study of Combination Therapy With Venetoclax Daratumumab and Dexamethasone (With and Without Bortezomib) in Subjects With Relapsed or Refractory Multiple Myeloma

This is a study of venetoclax, daratumumab, and dexamethasone with and without bortezomib combination therapy to evaluate safety, tolerability, and efficacy of these combinations in participants with relapsed or refractory multiple myeloma. The study will consist of 3 distinct parts: Part 1 includes participants with t(11;14) positive relapsed/refractory (R/R) multiple …

dexamethasone
bone marrow procedure
daratumumab
bortezomib
refractory multiple myeloma
St. Vincent's Hospital, Darlinghurst /ID# 165431
 (8.2 away) Contact site
  • 97 views
  • 30 Sep, 2020
  • +42 other locations
Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG

The purpose of this study is to investigate the activity of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive low grade glioma or relapsed or refractory high grade glioma.

BRAF
low grade glioma
measurable disease
progressive disease
vincristine
Novartis Investigative Site
 (6.9 away) Contact site
  • 325 views
  • 26 Oct, 2020
  • +79 other locations
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

Historically, medulloblastoma treatment has been determined by the amount of leftover disease present after surgery, also known as clinical risk (standard vs. high risk). Recent studies have shown that medulloblastoma is made up of distinct molecular subgroups which respond differently to treatment. This suggests that clinical risk alone is not …

corticosteroids
residual tumor
vincristine
primitive neuroectodermal tumor
tumor cells
Children's Hospital at Westmead
 (7.9 away) Contact site
  • 144 views
  • 18 Oct, 2020
  • +24 other locations
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

This research study is done to test how well different types of cancer respond to the drug called larotrectinib. The cancer must have a change in a particular gene (NTRK1, NTRK2 or NTRK3). Larotrectinib is a drug that blocks the actions of these NTRK genes in cancer cells and can …

cancer
NTRK
measurable disease
Macquarie University Hospital
 (1.3 away) Contact site
  • 0 views
  • 26 Nov, 2020
  • +171 other locations
A Phase II Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma

This is a Phase II, multicenter, open-label, single arm, 2-stage study of tazemetostat 800 mg BID (twice daily) and 1600 mg QD (once daily). Subjects will be screened for eligibility within 21 days of the planned date of the first dose of tazemetostat and enrolled into one of 8 cohorts: …

growth factor
ewing's sarcoma
extraskeletal myxoid chondrosarcoma
nitrosoureas
malignant peripheral nerve sheath tumor
Chris O'Brien Lifehouse
 (7.5 away) Contact site
  • 0 views
  • 28 Oct, 2020
  • +24 other locations
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of avelumab (MSB0010718C) in combination with other cancer immunotherapies in patients with locally advanced or metastatic solid tumors. The primary purpose is to assess the safety and early signs of efficacy of various avelumab …

metastasis
solid tumor
solid neoplasm
measurable disease
metastatic solid tumor
Macquarie University Hospital Pharmacy
 (1.3 away) Contact site
  • 193 views
  • 22 Nov, 2020
  • +113 other locations
Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy

An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). The first cohort will assess the objective response rate (ORR) of tipifarnib in subjects with HNSCC with HRAS mutations. The second study cohort, SEQ-HN, is an observational sub-study and includes 2 …

HRAS
neck cancer
caries
cancer
head and neck cancer
Royal North Shore Hospital
 (4.8 away) Contact site
  • 3 views
  • 02 Nov, 2020
  • +107 other locations
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the clinical efficacy and safety of combination therapy with guselkumab and golimumab in participants with moderately to severely active ulcerative colitis (UC).

golimumab
Macquarie University Hospital
 (1.3 away) Contact site
  • 65 views
  • 02 Dec, 2020
  • +159 other locations
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednisone per local regulation.

adenocarcinoma
androgens
prednisone
prostate cancer metastatic
metastatic prostate cancer
Macquarie University Hospital
 (1.3 away) Contact site
  • 501 views
  • 28 Nov, 2020
  • +122 other locations